Dxc Technology CO

Market Movers (8-K)

See all →
NYSE
DXC Technology appoints Paul Taylor as President and Dan Gray as President of Global Infrastructure Services to accelerate its AI-centric future.
NYSE
DXC Technology reported first quarter fiscal year 2027 results, with total revenue declining 5.1% year-over-year, but free cash flow significantly increasing to $314 million.
NYSE
DXC Technology Company held its 2026 Annual Meeting of Stockholders, with results reported for director elections, auditor ratification, executive compensation, and incentive plans.
NYSE
DXC Technology Company is hosting its Investor Day on June 11, 2026, and has posted its presentation materials online.
NYSE
DXC Technology announced its third quarter fiscal year 2026 results, reporting total revenue of $3.19 billion and diluted EPS of $0.61, alongside strong free cash flow.
NYSE
DXC Technology announced the full redemption of its 650 million Euro 1.750% Senior Notes due 2026 and a partial redemption of $300 million of its 1.800% Senior Notes due 2026, funded by a new 650 million Euro offering of 4.250% Senior Notes due 2030.
Worse than expected
Capital raise

Quarterly Earnings (10-Q)

See all →
NYSE
DXC Technology reported a 2.5% revenue decline to $3.16 billion in Q2 fiscal 2026, but saw a significant increase in year-to-date free cash flow to $337 million.
Worse than expected
Delay expected
NYSE
DXC Technology reported a decrease in first-quarter revenues and net income, alongside a goodwill impairment, while free cash flow improved and key legal proceedings saw resolutions.
Worse than expected
NYSE
DXC Technology's Q3 fiscal 2025 reveals a revenue decrease but an increase in adjusted diluted earnings per share.
Worse than expected
NYSE
DXC Technology reported a decrease in revenue and earnings per share for the second quarter of fiscal year 2025, while also showing improvements in free cash flow and adjusted earnings per share.
Worse than expected
NYSE
DXC Technology's first quarter fiscal 2025 results show a revenue decrease of 6.1% year-over-year, with diluted earnings per share at $0.14.
Worse than expected
NYSE
DXC Technology's Q3 results show a decrease in revenue but an increase in net income, alongside ongoing restructuring and cost optimization initiatives.
Better than expected

Annual Reports (10-K)

NYSE
DXC Technology's fiscal year 2025 reveals a revenue decrease of 5.8% alongside strategic restructuring and cost optimization efforts.
Worse than expected
NYSE
DXC Technology's fiscal year 2024 results show a revenue decrease but improved earnings per share, highlighting the company's ongoing strategic transformation.
Worse than expected

Insider Trading (Form 4)

See all →
NYSE
David L Herzog, a Director of DXC Technology Co, received 30,900 shares of common stock on August 4, 2026.
NYSE
Akihiko Washington, a Director of DXC Technology Co, received 21,800 shares of common stock on August 4, 2026.
NYSE
Anthony Gonzalez, a Director of DXC Technology Co, received 21,800 shares of common stock on August 4, 2026.
NYSE
David A Barnes, a Director of DXC Technology Co, received 21,800 shares of common stock on August 4, 2026.
NYSE
Dawn Rogers, a Director of DXC Technology Co, received 21,800 shares of common stock on August 4, 2026.
NYSE
Pinkie Dent Mayfield, a Director of DXC Technology Co, received 21,800 shares of common stock on August 4, 2026.

Proxy Statements (Def-14A)

NYSE
DXC Technology's 2026 Proxy Statement outlines director elections, executive compensation, and proposals to extend and increase share reserves for incentive plans.
Worse than expected
NYSE
DXC Technology Company has announced its 2025 Annual Meeting of Stockholders for July 22, 2025, seeking shareholder votes on the election of ten director nominees, ratification of its independent auditor, and approval of executive compensation.
NYSE
DXC Technology's latest proxy statement details a strategic pivot towards sustained, profitable growth, emphasizing strengthened leadership, AI integration, and a performance-driven culture, while reporting negative revenue growth and underperforming shareholder returns.
Worse than expected
NYSE
DXC Technology Company's upcoming annual meeting on July 30, 2024, will address key proposals including director elections, auditor ratification, executive compensation, and an increase in shares available under the director incentive plan.
NYSE
DXC Technology is holding its annual meeting of stockholders on July 30, 2024, to vote on key proposals including director elections, auditor ratification, executive compensation, and an increase in the director incentive plan.
Worse than expected

Schedule 13G - Passive Investments

See all →
NYSE
Glenview Capital Management, LLC and Larry Robbins have filed an amendment to their Schedule 13G, reporting no beneficial ownership of DXC Technology Co. common stock as of June 30, 2026.
NYSE
American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively increased their beneficial ownership of DXC Technology Company's common stock to 6.4%.
NYSE
Millennium Management LLC, along with affiliated entities and Israel A. Englander, has filed a Schedule 13G amendment, reporting beneficial ownership of 4.1% of DXC Technology Company's common stock.
NYSE
Dimensional Fund Advisors LP has disclosed beneficial ownership of 5.0% of DXC Technology Co.'s common stock, holding 8,058,153 shares.
NYSE
Millennium Management LLC and Israel A. Englander have reported a 5.7% beneficial ownership stake in DXC Technology Company.
NYSE
American Century Investment Management and affiliated entities have reported a 5.4% beneficial ownership stake in DXC Technology Company.